TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).

Neeraj Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.